Bay Street News, 2019

SOUTH SAN FRANCISCO, Calif., Nov. 11, 2019 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering […]

SAN DIEGO, Nov. 11, 2019 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel […]

NEW YORK, Nov. 11, 2019 (GLOBE NEWSWIRE) — FTE Networks, Inc. (NYSE American: FTNW) (“FTE” or the “Company”) today announced […]

NEODESHA, Kan., Nov. 11, 2019 (GLOBE NEWSWIRE) — AgEagle Aerial Systems, Inc. (NYSE American: UAVS), an industry leading provider of […]

SAN FRANCISCO and HERZLIYA, Israel, Nov. 11, 2019 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on […]

TORONTO, Nov. 11, 2019 (GLOBE NEWSWIRE) — Sparton Resources Inc. (TSXV: SRI) (“Sparton” or the “Company“) announced today that it […]

Median ACR CRISS score remains 0.95 at 25 months in systemic sclerosis OLEImprovement in CDASI activity score reaches -20.9 points […]

TORONTO, Nov. 11, 2019 (GLOBE NEWSWIRE) — THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT IS QUALIFIED OR MAY […]

-CDX-0159 IND accepted; Phase 1 study to start by YE 2019--CDX-527 on track for IND filing in 1H 2020-HAMPTON, N.J., […]

HOLLYWOOD, Fla., Nov. 11, 2019 (GLOBE NEWSWIRE) — NV5 Global, Inc. (the “Company” or “NV5”) (Nasdaq: NVEE), a provider of […]